Notably, pre-clinical and clinical studies have clarified the roles of cytotoxic CD4+ T cells in various human cancer types, including breast cancer, in which intra-tumoral CD4+ T cells that express cytolytic proteins, such as granzymes, can directly kill tumor cells independently of conventional CD8+ T cells 67. This evidence concerns the gene CD8A and neoplasm.